Stealth BioTherapeutics' filing for rare disease drug elamipretide has been turned down by the FDA, although the company says the US regulator has given it a "path forward" for the programme.
Barchart on MSN
Jeff Bezos Launched a Secretive AI Startup in 2025 That Should Give Wall Street Chills
Amazon founder Jeff Bezos is placing a huge bet on the future of AI. If he’s right, it could transform manufacturing and ...
It was the night the lights went out in Caracas. The pre-dawn raid that saw U.S. special operations forces seize President ...
Two Y Combinator veterans behind a nine-figure exit have now raised $15 million, led by YC CEO Garry Tan, to build an ...
India Today on MSNOpinion
How collapse of Chinese air cover during US strikes on Venezuela validates India's defence doctrine
The Venezuela operation exposes the limitations of Chinese systems while endorsing India's emphasis on layered, battle-tested ...
In terms of monumental years in fashion, 2025 is surely up there. Perhaps not since 1947 when Christian Dior debuted his ‘New ...
The LCA Mk1A is an advanced variant designed to meet the Indian Air Force's operational requirements, while the LCA Mk II and the naval variant are currently under development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback